HIV-1 Envelope Glycoprotein-Mediated Fusion and Pathogenesis: Implications for Therapy and Vaccine Development

Vaccine - Netherlands
doi 10.1016/j.vaccine.2007.12.026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

HIV Entry and Envelope Glycoprotein-Mediated Fusion

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

HIV-1 Envelope Resistance to Proteasomal Cleavage: Implications for Vaccine Induced Immune Responses

PLoS ONE
Multidisciplinary
2012English

Self-Assembling Protein Nanoparticles: Implications for HIV-1 Vaccine Development

Nanomedicine
DevelopmentMaterials ScienceNanoscienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2018English

cGMP Production and Analysis of BG505 SOSIP.664, an Extensively Glycosylated, Trimeric HIV-1 Envelope Glycoprotein Vaccine Candidate

Biotechnology and Bioengineering
Applied MicrobiologyBiotechnologyBioengineering
2017English

Foamy Virus Envelope Glycoprotein-Mediated Entry Involves a pH-Dependent Fusion Process

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2003English

Structure of the Transmembrane Domain of HIV-1 Envelope Glycoprotein

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2016English

Apoptosis and Karyogamy in Syncytia Induced by the HIV-1-envelope Glycoprotein Complex

Cell Death and Differentiation
Cell BiologyMolecular Biology
2000English

Development of Indole Compounds as Small Molecule Fusion Inhibitors Targeting HIV-1 Glycoprotein-41

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2011English

Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design

Frontiers in Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy